Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy

EB
HCPCS Modifier Code

2023 HCPCS Modifiers
Billable/Valid Code

EB is a valid 2023 HCPCS Modifier that could be used to indicate Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy.

EB Modifier has been in effect since Jan 01, 2008.

Short description for EB HCPCS Modifier code:

Esa, anemia, radio-induced

HCPCS EB MODIFIER

EB Modifier information

Modifier:	EB
Description:	ERYTHROPOETIC STIMULATING AGENT (ESA) ADMINISTERED TO TREAT ANEMIA DUE TO ANTI-CANCER RADIOTHERAPY
Effective Date:	Jan 01, 2008
Added Date:	Jan 01, 2008
Coverage code:	`D` - SPECIAL COVERAGE INSTRUCTIONS APPLY
Action code:	`N` - NO MAINTENANCE FOR THIS CODE